Hinge Health, Inc. Class A Common Stock (HNGE)
R&D Expense Growth
12.26%
Quarterly · Period ending:
HNGE R&D Expense Growth
Latest reported12.26%period ending
Latest reported12.26%period ending
HNGE Quarterly R&D Growth (QoQ) (0.00% → 12.26%)
Latest values, visible window
High-resolution chart · PNG
HNGE r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 12.2586% | |
| -7.379% | |
| 2.6127% | |
| -88.5981% | |
| 1,091.3277% | |
| 5.0467% | |
| -5.9449% | |
| -4.5546% | |
| -18.9936% | |
| 7.6457% | |
| 0.4252% | |
| 2.3633% | |
| 0% |